Peritoneal Carcinomatosis of Gastric Origin: a Population-based Study on Incidence, Survival and Risk Factors
Overview
Authors
Affiliations
Peritoneal carcinomatosis (PC) is an important cause of morbidity and mortality among patients with gastric cancer. The aim of the current study was to provide reliable population-based data on the incidence, risk factors and prognosis of PC of gastric origin. All patients diagnosed with gastric cancer in the area of the Eindhoven Cancer Registry between 1995 and 2011 were included. Incidence and survival were computed and risk factors for peritoneal carcinomatosis were determined using multivariate logistic regression analysis. In total, 5,220 patients were diagnosed with gastric cancer, of whom 2,029 (39%) presented with metastatic disease. PC was present in 706 patients (14%) of whom 491 patients (9%) had PC as the only metastatic site. Younger age (<60 years), female gender, advanced T- and N-stage, primary tumor of signet ring cells or linitis plastica and primary tumors covering multiple anatomical locations of the stomach were all associated with a higher odds ratios of developing PC. Median survival of patients without metastases was 14 months, but only 4 months for patients with PC. PC is a frequent condition in patients presenting with gastric cancer, especially in younger patients with advanced tumor stages. Given the detrimental influence of PC on survival, efforts should be undertaken to further explore the promising results that were obtained in preventing or treating this condition with multimodality strategies.
Guchelaar N, de Neijs M, Noordman B, Graaf H, van Hellemond I, van der Sluis P EClinicalMedicine. 2025; 81:103109.
PMID: 40026831 PMC: 11872448. DOI: 10.1016/j.eclinm.2025.103109.
Educational Review: Updates on Therapeutic Strategies for Gastric Cancer with Peritoneal Metastasis.
Lewis K, Diggs L, Badgwell B Ann Surg Oncol. 2025; .
PMID: 40016614 DOI: 10.1245/s10434-025-17069-3.
Mano Y, Igarashi Y, Komori K, Hashimoto I, Watanabe H, Takahashi K Front Immunol. 2025; 16:1521278.
PMID: 39949777 PMC: 11821591. DOI: 10.3389/fimmu.2025.1521278.
Iterative Intraperitoneal Chemotherapy in Gastric Cancer Peritoneal Carcinomatosis.
Tajik F, Eyob B, Khan A, Radhakrishnan V, Senthil M Cancers (Basel). 2025; 17(2).
PMID: 39858070 PMC: 11763546. DOI: 10.3390/cancers17020289.
Gong Z, Zhou L, He Y, Zhou J, Deng Y, Huang Z Front Oncol. 2025; 14():1503045.
PMID: 39850825 PMC: 11754059. DOI: 10.3389/fonc.2024.1503045.